Andrew Z. Wang

20.8k total citations · 7 hit papers
268 papers, 16.2k citations indexed

About

Andrew Z. Wang is a scholar working on Biomedical Engineering, Oncology and Biomaterials. According to data from OpenAlex, Andrew Z. Wang has authored 268 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Biomedical Engineering, 78 papers in Oncology and 75 papers in Biomaterials. Recurrent topics in Andrew Z. Wang's work include Nanoparticle-Based Drug Delivery (68 papers), Nanoplatforms for cancer theranostics (45 papers) and RNA Interference and Gene Delivery (26 papers). Andrew Z. Wang is often cited by papers focused on Nanoparticle-Based Drug Delivery (68 papers), Nanoplatforms for cancer theranostics (45 papers) and RNA Interference and Gene Delivery (26 papers). Andrew Z. Wang collaborates with scholars based in United States, China and South Korea. Andrew Z. Wang's co-authors include Omid C. Farokhzad, Róbert Langer, Frank Gu, Juliana M. Chan, Joseph M. Caster, Yuanzeng Min, Liangfang Zhang, Aleksandar F. Radovic‐Moreno, Michael J. Eblan and Edina C. Wang and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Andrew Z. Wang

247 papers receiving 15.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles in Medicine: Therapeutic Applications and Developments

2007 1.9k citations Frank Gu, Andrew Z. Wang et al. profile →
Nanoparticle Delivery of Cancer Drugs

2011 1.2k citations Andrew Z. Wang, Róbert Langer et al. profile →
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform

2008 851 citations Liangfang Zhang, Frank Gu et al. ACS Nano profile →
Clinical Translation of Nanomedicine

2015 628 citations Yuanzeng Min, Joseph M. Caster et al. profile →
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

2017 590 citations Yuanzeng Min, Kyle C. Roche et al. profile →
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

2008 577 citations Frank Gu, Liangfang Zhang et al. Proceedings of the National Academy of Sciences profile →
Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles

2011 461 citations Andrew Z. Wang et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Andrew Z. Wang

Since Specialization

Citations

This map shows the geographic impact of Andrew Z. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Z. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Z. Wang more than expected).

Fields of papers citing papers by Andrew Z. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Z. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Z. Wang. The network helps show where Andrew Z. Wang may publish in the future.

Co-authorship network of co-authors of Andrew Z. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Z. Wang. A scholar is included among the top collaborators of Andrew Z. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Z. Wang. Andrew Z. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enantioselective and Diastereoselective Synthesis of Azaspiro[n.2]alkanes by Rhodium-Catalyzed Cyclopropanations 2025 ·ACS Catalysis ·(unknown), (unknown), Andrew Z. Wang, Djamaladdin G. Musaev, Huw M. L. Davies	2
2	Nanotherapeutic Wee1 Inhibition Sensitizes Tumor Ferroptosis to Promote Cancer Immunotherapy and Abscopal Effect 2025 ·ACS Nano ·Peijie Zhou, (unknown), (unknown), (unknown), Dong Qian, Xin Ming, Andrew Z. Wang, Xiaoyuan Chen, Yuanzeng Min	0
3	2022TiP Stereotactic treatment with neoadjuvant radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV) 2024 ·Annals of Oncology ·Tian Zhang, Solomon L. Woldu, Qian Qin, Suzanne Cole, (unknown), (unknown), Jing Wang, Kevin D. Courtney, (unknown), Rafał Płoski, (unknown), Daniel X. Yang, (unknown), Isamu Tachibana, Kris E. Gaston, Andrew Z. Wang, (unknown), Yair Lotan, Neil Desai	1
4	Multiple sclerosis treatments a review of current biomedical engineering approaches 2024 ·Biomaterials ·(unknown), Kin Man Au, (unknown), (unknown), Olaf Stüve, Andrew Z. Wang	5
5	Treatment outcomes for patients with Ga68-PSMA-PET prostate cancer (PC) with or without conventional imaging correlates. 2024 ·Journal of Clinical Oncology ·(unknown), Maureen Aliru, (unknown), Song Zhang, (unknown), (unknown), Jue Wang, (unknown), Kevin D. Courtney, Daniel X. Yang, Neil Desai, Aurélie Garant, Raquibul Hannan, Jeffrey A. Cadeddu, Kris E. Gaston, Solomon L. Woldu, Vitaly Margulis, Yair Lotan, Andrew Z. Wang, Tian Zhang	0
6	Effects of Bioactive Glasses (BGs) on Exosome Production and Secretion: A Critical Review 2023 ·Materials ·(unknown), Seyede Atefe Hosseini, Andrew Z. Wang, Francesco Baino, Saeid Kargozar	2
7	Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients 2023 ·Biosensors and Bioelectronics ·Michael J. Poellmann, Jiyoon Bu, Stanley K. Liu, Andrew Z. Wang, Steven N. Seyedin, Chandrikha Chandrasekharan, (unknown), Young Soo Kim, Joseph M. Caster, Seungpyo Hong	14
8	Prospective Characterization of Circulating Tumor Cell Kinetics in Patients With Oligometastatic Disease Receiving Definitive Intent Radiation Therapy 2023 ·JCO Precision Oncology ·(unknown), Michael J. Poellmann, (unknown), Xianming Tan, Jiyoon Bu, Ja Hye Myung, Andrew Z. Wang, Seungpyo Hong, Dana L. Casey	5
9	Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis 2021 ·Cancer Research ·Hossein Sendi, Mostafa Yazdimamaghani, Mengying Hu, (unknown), Jie Wang, Amber S. Moody, (unknown), Jiajie Zhang, Amanda L. Graboski, (unknown), Juan D. Rojas, Paul A. Dayton, Leaf Huang, Andrew Z. Wang	53
10	Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models 2021 ·Acta Biomaterialia ·(unknown), C. Tilden Hagan, (unknown), Xi Tian, Feifei Yang, Kin Man Au, Yu Mi, Yusra B. Medik, Kyle C. Roche, Kyle Wagner, Zachary L. Rodgers, Yuanzeng Min, Andrew Z. Wang	54
11	Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling 2020 ·SHILAP Revista de lepidopterología ·Lin Shi, Han Wang, Wei Yang, Andrew Z. Wang, Cuizhi Geng	1
12	Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine 2020 ·Bioconjugate Chemistry ·C. Tilden Hagan, Yu Mi, (unknown), Andrew Z. Wang	16
13	Assessing Changes in Circulating Tumor Cells (CTCs) during Preoperative Chemoradiotherapy for Gastrointestinal Malignancies Using a Nanotechnology-Based CTC Capture System 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Steven N. Seyedin, (unknown), Michael J. Poellmann, Jiyoon Bu, Andrew Z. Wang, Seungpyo Hong, Joseph M. Caster	2
14	Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture 2018 ·Clinical Cancer Research ·Ja Hye Myung, Michael J. Eblan, Joseph M. Caster, (unknown), Michael J. Poellmann, Kyle Wang, (unknown), Seth Miller, Colette J. Shen, Ronald C. Chen, Tian Zhang, Joel E. Tepper, Bhishamjit S. Chera, Andrew Z. Wang, Seungpyo Hong	34
15	Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma 2018 ·ACS Nano ·Kin Man Au, Ashutosh Tripathy, (unknown), Kyle Wagner, Seungpyo Hong, Andrew Z. Wang, Steven I. Park	46
16	Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer 2018 ·ACS Nano ·Xiaomeng Wan, Yuanzeng Min, Herdis Bludau, Andrew N. Keith, Sergei S. Sheiko, Rainer Jordan, Andrew Z. Wang, Marina Sokolsky‐Papkov, Alexander V. Kabanov	132
17	Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Dominic H. Moon, Autumn J. McRee, A. William Blackstock, Bert H. O’Neil, Dominic T. Moore, Benjamin F. Calvo, (unknown), (unknown), (unknown), (unknown), Adrian M. Senderowicz, Joel E. Tepper, Hanna K. Sanoff, Andrew Z. Wang	1
18	Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models 2017 ·Journal of Materials Chemistry B ·Jing Tian, Yuanzeng Min, Zachary L. Rodgers, Kin Man Au, C. Tilden Hagan, (unknown), Kyle C. Roche, Feifei Yang, Kyle Wagner, Andrew Z. Wang	48
19	CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α 2016 ·Cancer Research ·Xi Tian, Minh Nguyen, Henry P. Foote, Joseph M. Caster, Kyle C. Roche, Christian Peters, Pauline Wu, Lata Jayaraman, Edward G. Garmey, Joel E. Tepper, Scott Eliasof, Andrew Z. Wang	72
20	Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers breakdown → 2008 ·Proceedings of the National Academy of Sciences ·Frank Gu, Liangfang Zhang, Benjamin A. Teply, Nina Mann, Andrew Z. Wang, Aleksandar F. Radovic‐Moreno, Róbert Langer, Omid C. Farokhzad	577

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact